Watch GRDN. Know when insiders buy.
One email the day a filing lands. Free.
GRDN
Guardian Pharmacy Services, Inc.
46.52
−1.48 −3.08%
USD · close Sep 16
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
47
WATCH · shorts 47
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $1.5B +10.3%NET INCOME $65.9MNET CASH $89.8M52W 23.41 – 48.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $351.8M | +2.2% | 22.8% | $20.6M | $21.9M | +142.2% | — | $30M | — | — | Aug 6 |
| Q1 2026 · Mar 31 | $336.6M | +2.2% | 22.7% | $17.7M | $13.3M | +40.7% | — | $6.1M | — | — | Aug 6 |
| Q4 2025 · Dec 31derived | $397.6M | +17.4% | 21.5% | $30.8M | $20.9M | +75.2% | — | $34.6M | $495K | $34.1M | Mar 11 |
| Q3 2025 · Sep 30 | $377.4M | +20.0% | 19.8% | $16.4M | $9.8M | — | — | $28.2M | $4M | $24.2M | Nov 10 |
| Q2 2025 · Jun 30 | $344.3M | +14.8% | 19.8% | $12.6M | $9M | — | — | $19.9M | — | — | Aug 6 |
| Q1 2025 · Mar 31 | $329.3M | +19.6% | 19.5% | $13M | $9.4M | +33.2% | — | $17.6M | — | — | Aug 6 |
| Q4 2024 · Dec 31derived | $338.6M | +28.9% | 19.8% | $16.8M | $11.9M | — | — | $22.3M | $2.3M | $20.1M | Mar 11 |
| Q3 2024 · Sep 30 | $314.4M | — | 19.4% | −$104.6M | −$122M | — | — | −$2.2M | $2.2M | −$4.4M | Nov 10 |
| Q2 2024 · Jun 30 | $300M | — | 20.4% | $17M | $0 | — | — | $29.1M | — | — | Aug 11 |
| Q1 2024 · Mar 31 | $275.4M | — | 20.0% | $7.9M | $7.1M | — | — | $8.7M | — | — | Nov 10 |
| Q3 2023 · Sep 30 | $262.7M | — | 19.9% | −$6.3M | −$7M | — | — | — | — | — | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.4B | 20.2% | $72.7M | $49.2M | 3.4% | — | $100.3M | $13.4M | $86.8M | — | — |
| FY2024 · to Dec 31 | $1.2B | 19.9% | −$62.9M | −$110M | -9.0% | — | $58M | $14.7M | $43.3M | — | — |
Every number comes from Guardian Pharmacy Services, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.